Adam Ruth Selected Research

Schizophrenia (Dementia Praecox)

1/2018	Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.
12/2015	Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.
8/2015	Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.
2/2015	The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
2/2014	An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam Ruth Research Topics

Disease

8	Major Depressive Disorder (Major Depressive Disorders) 10/2016 - 04/2013
6	Psychomotor Agitation (Akathisia) 12/2015 - 02/2014
5	Schizophrenia (Dementia Praecox) 01/2018 - 02/2014
5	Mania (Manias) 11/2015 - 02/2014
4	Basal Ganglia Diseases (Basal Ganglia Disease) 08/2015 - 02/2014
3	Tremor (Tremors) 08/2015 - 03/2015
3	Constipation 03/2015 - 02/2014
3	Nausea 03/2015 - 02/2014
2	Anxiety Disorders (Anxiety Disorder) 01/2016 - 01/2016
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2015 - 02/2014
2	Headache (Headaches) 12/2015 - 02/2015
2	Dyspepsia (Indigestion) 03/2015 - 02/2015
1	Fatigue 03/2016
1	Medically Unexplained Symptoms 03/2016
1	Ejaculatory Dysfunction 01/2016
1	Erectile Dysfunction 01/2016
1	Vomiting 03/2015
1	Parkinsonian Disorders (Parkinsonism) 02/2015
1	Dizziness (Lightheadedness) 02/2014
1	Carcinoma (Carcinomatosis) 01/2010
1	Papillomavirus Infections 11/2007
1	Genomic Instability 11/2007

Drug/Important Bio-Agent (IBA)

8	cariprazineIBA 01/2018 - 02/2014
5	LevomilnacipranIBA 10/2016 - 04/2013
4	Vilazodone HydrochlorideIBA 01/2016 - 03/2014
2	Dopamine (Intropin)FDA LinkGeneric 08/2015 - 02/2015
1	Aripiprazole (Abilify)FDA Link 12/2015
1	Serotonin (5 Hydroxytryptamine)IBA 01/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2015
1	5-HT1A Serotonin ReceptorIBA 03/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2014
1	Antidepressive Agents (Antidepressants)IBA 04/2013
1	telomerase RNA (bTR)IBA 01/2010
1	Biomarkers (Surrogate Marker)IBA 11/2007